Credit Suisse’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $14.4M | Sell |
954,929
-369,818
| -28% | -$6.71M | 0.01% | 759 |
|
|
2023
Q4 | $28.5M | Sell |
1,324,747
-82,883
| -6% | -$1.53M | 0.03% | 556 |
|
|
2023
Q3 | $26.2M | Sell |
1,407,630
-126,321
| -8% | -$2.95M | 0.03% | 573 |
|
|
2023
Q2 | $38.8M | Sell |
1,533,951
-128,336
| -8% | -$3.23M | 0.04% | 469 |
|
|
2023
Q1 | $43.1M | Sell |
1,662,287
-162,660
| -9% | -$4.35M | 0.04% | 441 |
|
|
2022
Q4 | $43.2M | Sell |
1,824,947
-480,596
| -21% | -$13M | 0.05% | 438 |
|
|
2022
Q3 | $58.4M | Sell |
2,305,543
-211,399
| -8% | -$7.42M | 0.07% | 325 |
|
|
2022
Q2 | $83.6M | Buy |
2,516,942
+266,288
| +12% | +$11.3M | 0.09% | 237 |
|
|
2022
Q1 | $162M | Sell |
2,250,654
-37,184
| -2% | -$2.68M | 0.14% | 145 |
|
|
2021
Q4 | $210M | Sell |
2,287,838
-23,980
| -1% | -$2.87M | 0.11% | 175 |
|
|
2021
Q3 | $293M | Buy |
2,311,818
+107,660
| +5% | +$15.7M | 0.16% | 111 |
|
|
2021
Q2 | $378M | Buy |
2,204,158
+383,991
| +21% | +$62.2M | 0.2% | 77 |
|
|
2021
Q1 | $331M | Buy |
1,820,167
+293,115
| +19% | +$68M | 0.17% | 103 |
|
|
2020
Q4 | $305M | Buy |
1,527,052
+841,075
| +123% | +$171M | 0.15% | 131 |
|
|
2020
Q3 | $150M | Buy |
685,977
+75,008
| +12% | +$15.9M | 0.09% | 233 |
|
|
2020
Q2 | $117M | Buy |
610,969
+108,178
| +22% | +$19M | 0.08% | 241 |
|
|
2020
Q1 | $77.9M | Sell |
502,791
-527,651
| -51% | -$61.4M | 0.07% | 281 |
|
|
2019
Q4 | $86.3M | Sell |
1,030,442
-84,912
| -8% | -$6.46M | 0.06% | 328 |
|
|
2019
Q3 | $75.5M | Buy |
1,115,354
+2,950
| +0.3% | +$194K | 0.06% | 306 |
|
|
2019
Q2 | $73.9M | Buy |
1,112,404
+30,442
| +3% | +$1.77M | 0.07% | 304 |
|
|
2019
Q1 | $60.2M | Sell |
1,081,962
-124,207
| -10% | -$7.58M | 0.05% | 352 |
|
|
2018
Q4 | $59.8M | Buy |
1,206,169
+306,292
| +34% | +$18.7M | 0.06% | 315 |
|
|
2018
Q3 | $77.7M | Sell |
899,877
-18,149
| -2% | -$1.29M | 0.07% | 282 |
|
|
2018
Q2 | $53.3M | Sell |
918,026
-685,491
| -43% | -$33.5M | 0.05% | 371 |
|
|
2018
Q1 | $64.6M | Buy |
1,603,517
+616,904
| +63% | +$23.3M | 0.06% | 340 |
|
|
2017
Q4 | $34.4M | Buy |
986,613
+847,648
| +610% | +$28.1M | 0.03% | 591 |
|
|
2017
Q3 | $4.61M | Buy |
138,965
+89,706
| +182% | +$2.94M | ﹤0.01% | 1825 |
|
|
2017
Q2 | $1.71M | Buy |
49,259
+30,865
| +168% | +$899K | ﹤0.01% | 2332 |
|
|
2017
Q1 | $459K | Sell |
18,394
-880
| -5% | -$18.3K | ﹤0.01% | 3339 |
|
|
2016
Q4 | $318K | Buy |
19,274
+7,219
| +60% | +$123K | ﹤0.01% | 3634 |
|
|
2016
Q3 | $221K | Buy |
12,055
+498
| +4% | +$8.73K | ﹤0.01% | 3774 |
|
|
2016
Q2 | $185K | Sell |
11,557
-71,160
| -86% | -$830K | ﹤0.01% | 3898 |
|
|
2016
Q1 | $794K | Buy |
+82,717
| New | +$1.17M | ﹤0.01% | 2895 |
|
|
2015
Q4 | – | Sell |
-26,056
| Closed | -$580K | – | 4354 |
|
|
2015
Q3 | $580K | Buy |
+26,056
| New | +$704K | ﹤0.01% | 3288 |
|
Other funds holding TDOC
AIM
NAMA
Credit Suisse's TDOC Position: Q1 2024 in Review
Credit Suisse reduced its Teladoc Health (TDOC) stake by 28% in Q1 2024, selling an estimated $6.71M and leaving 954,929 shares worth $14.4M. The position accounts for 0.01% of the portfolio, ranked #759.
Credit Suisse first reported a position in TDOC in Q3 2015 and has held it in 34 quarters since. The position peaked at $378M in Q2 2021. 426 funds tracked by Wall St. Rank hold TDOC as of Q1 2024.
- Credit Suisse held 954,929 shares of Teladoc Health worth $14.4M as of Q1 2024.
- Credit Suisse sold 369,818 Teladoc Health shares in Q1 2024, an estimated $6.71M.
- Teladoc Health made up 0.01% of Credit Suisse's portfolio in Q1 2024, its #759 holding.
- Credit Suisse first reported a position in Teladoc Health in Q3 2015 and has held it in 34 quarters since.
- Credit Suisse's Teladoc Health position peaked at $378M in Q2 2021.
- 426 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2024.
Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.